Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcb5660d695d90496921ee76a4f592a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3871ca184a5ccebad6005563f511753 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_817c10e38a20d290eb13a2c2c8645483 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c1dff5d2a51b05d8288101f57a32a7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55d635e782a809567a34cd2f50bc440a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
filingDate |
2007-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92e75ec2edd5b09e2cbd2dca8daec6e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c83bb389a3a7d097a6214b1eb7c61a00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d5179086123579824274a2ce24ba5b2 |
publicationDate |
2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8318792-B2 |
titleOfInvention |
Therapeutic agent for amyotrophic lateral sclerosis |
abstract |
A method for treating amyotrophic lateral sclerosis is disclosed wherein a compound having xanthine dehydrogenase inhibiting activity is administered. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018092911-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10682372-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881662-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344539-B2 |
priorityDate |
2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |